Investor mix
14 investors on record; lead investors include HBM Healthcare Investments.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 8 | 57% |
| Private equity | 2 | 14% |
| Other / undisclosed | 4 | 29% |
Developer of novel immunotherapies for asthma treatment
14 investors on record; lead investors include HBM Healthcare Investments.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 8 | 57% |
| Private equity | 2 | 14% |
| Other / undisclosed | 4 | 29% |